asymptomatic patients – Page 12 – Communicable Diseases Research

Asymptomatic COVID‐19: disease tolerance with efficient anti‐viral immunity against SARS‐CoV‐2

무증상 COVID-19: SARS-CoV-2에 대한 효율적인 항바이러스 면역으로 질병 내성

Article

Published on 2021-05-272022-09-11
Journal: EMBO Molecular Medicine [Category] MERS, SARS, 바이오마커, 유전자 메커니즘,

Multi-modality detection of SARS-CoV-2 in faecal donor samples for transplantation and in asymptomatic emergency surgical admissions

이식 및 무증상 응급 수술 입원을 위한 대변 기증자 샘플에서 SARS-CoV-2의 다중 양식 검출

Brief Report

Published on 2021-05-112022-09-11
Journal: F1000Research [Category] MERS, SARS, 치료기술,

Dynamic and features of SARS-CoV-2 infection in Gabon

가봉 SARS-CoV-2 감염의 역학 및 특징

Article

Published on 2021-05-062022-09-01
Journal: Scientific Reports [Category] SARS, 유전자 메커니즘, 진단,

[키워드] accounted African age age distribution Ageusia Analysis analyzed Anosmia anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody Antibody Response Asthma Asymptomatic asymptomatic patient asymptomatic patients Blood Blood cells blood type Blood types calculated children chronic disease Chronic diseases clinical feature Clinical features Cohort community transmission Contact COVID-19 COVID-19 patient COVID-19 severity Critical Critical disease Critical illness cured death described diabetes diagnosed Diagnosis Disease prevention distribution driving dynamic Dyspnea Epidemiology feature female Gabon Gender hypertension Infection infection rate Influenza influenza-like symptom Influenza-like symptoms information leukocytes Leukocytosis leukopenia lowest lymphocyte Lymphocyte count lymphocytopenia male median Mild-to-moderate mild-to-moderate disease neutrophil neutrophilia neutrophilic leukocytosis Neutrophils Outcomes research participant Patient positive positive patient proportion provided public health rate of infection recorded representing Respiratory failure RT-PCR SARS-CoV-2 SARS-CoV-2 infected subject SARS-CoV-2 infected subjects SARS-COV-2 infection SARS-CoV-2 RT-PCR screened Spectrum subclinical infection Treatment protocol White blood cell White blood cells
[DOI] 10.1038/s41598-021-87043-y PMC 바로가기 [Article Type] Article

Angiotensin-converting enzyme-1 gene insertion/deletion polymorphism may be associated with COVID-19 clinical severity: a prospective cohort study

안지오텐신 전환 효소-1 유전자 삽입/제거 다형성이 COVID-19 임상 중증도와 관련될 수 있음: 전향적 코호트 연구

Article

Published on 2021-05-012022-09-11
Journal: Annals of Saudi medicine [Category] 바이오마커, 변종,

[키워드] 95 % CI 95% CI ACE advanced age agarose gel electrophoresis age angiotensin Asymptomatic Asymptomatic disease asymptomatic patients Care Chain Reaction Clinical data Clinical severity cohort study collected Comorbidity conflict conflict of interest COVID-19 COVID-19 infection COVID-19 patient COVID-19 patients determined by diabetes Diabetes Mellitus died disease disease severity dominant enzyme frequencies Frequency Genotype heart disease hospital I/D I/D genotype I/D polymorphism independent risk factor independent risk factors insertion/deletion ischemic heart disease Mild nine outcome Pathogenesis Patient polymerase chain polymerase chain reaction polymorphism Prospective prospective cohort study Protective Sample Sample size severe COVID-19 severe disease significantly single center small sample size Tertiary whole blood sample with COVID-19
[DOI] 10.5144/0256-4947.2021.141 PMC 바로가기 [Article Type] Article

Pitfall of Universal Pre-Admission Screening for SARS-CoV-2 in a Low Prevalence Country

낮은 유병률 국가에서 SARS-CoV-2에 대한 보편적인 사전 입학 심사의 함정

Article

Published on 2021-04-302022-09-01
Journal: Viruses [Category] MERS, SARS, 진단,

Performance of Unobserved Self-Collected Nasal Swabs for Detection of SARS-CoV-2 by RT-PCR Utilizing a Remote Specimen Collection Strategy

Major Articles

Published on 2021-04-282022-10-29
Journal: Open Forum Infectious Diseases [Category] COVID-19,

[키워드] acute respiratory syndrome alleviate amplify asymptomatic patients authorization Care Cohort Collection coronavirus coronavirus disease COVID-19 cycle threshold decrease detection Emergency examined False negative false-negative Health Inconclusive interquartile range likelihood median methodology N-gene nasal swab participant Participants Patient performance Personal protective equipment polymerase chain positive PPE provide quest remote Result reverse transcription risk RNase P RT-PCR RT-PCR test SARS-CoV-2 SARS-CoV-2 RT-PCR self-collection significantly higher specimen specimens Strategy symptomatic Symptoms target tested
[DOI] 10.1093/ofid/ofab039 PMC 바로가기 [Article Type] Major Articles

Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial

무증상 및 경증 COVID-19 환자에 대한 nelfinavir의 효능 및 안전성: 다기관, 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약

Letter

Published on 2021-04-282022-09-10
Journal: Trials [Category] SARS, 임상, 치료기술,

[키워드] 1:1 Administered administration adverse event adverse events age all-cause mortality ALT Analysis anticipated Antigen antiviral efficacy AST Asymptomatic asymptomatic patients blinded blinded outcome assessment Blinding blood glucose body temperature both group both groups capture caused childbearing potential clearance clinical Clinical efficacy clinical examinations Clinical symptoms clinical trial clinical trials comparator Patients condition Consent contraceptive method Controlled clinical trial cough COVID-19 creatinine creatinine clearance dataset Day defervescence diabete diabetes diarrhea discretion dissemination distribution drug element enrolled enrolment evaluate event exclusion criteria exploratory Factor female patient Fever Frequency Glucose group hazard ratio Hemophiliac Hemorrhagic history HIV infection hospital hypersensitivity incidence incidence rate Inclusion inclusion and exclusion criteria inclusion criteria Infection Informed consent initial investigator investigator-initiated investigators Japan Japanese LAMP limit log-rank test male Mild mild COVID-19 patient Mild disease mixed-effects model multicenter Nasopharyngeal swab Negative conversion Negative PCR nelfinavir null hypothesis number objective Open-label outcome oxygen Oxygen administration p value parallel group parameter participant Patient patients with asymptomatic PCR PCR test Pneumonia power Pregnancy primary endpoint Primary outcome principal investigator Probability probability distribution protocol random randomization Randomized Randomized controlled trial Registered registry reported required respiratory tract rifampicin room air safety endpoint Saliva saliva samples Sample size SARS-CoV-2 SARS-CoV-2 vaccination secondary efficacy endpoint serious complication serum creatinine severity specimen Standard status study period Study protocol supplementary material survival survival function Symptom symptomatic symptomatic COVID-19 Symptomatic treatment the log-rank test Three times daily Treatment treatment for HIV treatment period Trial Trial registration two-sided Unsuitable Viral viral dynamics Viral load virus was determined website Withdrawal withdrawal of consent
[DOI] 10.1186/s13063-021-05282-w PMC 바로가기 [Article Type] Letter

Investigating the utility of COVID-19 antibody testing in end-stage renal disease patients receiving haemodialysis: a cohort study in the United Kingdom

혈액투석을 받는 말기 신질환 환자에서 COVID-19 항체 검사의 유용성 조사: 영국의 코호트 연구

Research

Published on 2021-04-272022-09-10
Journal: BMC Nephrology [Category] MERS, SARS, 치료기술,

[키워드] addition aims Analysis anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody anti-SARS-CoV-2 IgG anti-SARS-CoV-2 IgG antibodies anti-SARS-CoV-2 IgG antibody antibodies Antibody Response Antibody testing approved asymptomatic patient asymptomatic patients baseline characteristics Chain Reaction Characteristics Chi-squared test Chi-squared tests cohort study COVID-19 COVID-19 antibody COVID-19 infection death detectable detectable anti-SARS-CoV-2 antibodies determine diagnosis of COVID-19 disease End-stage renal disease epidemiological ESRD groups Haemodialysis help Hope hospital host immunity humoral Humoral response IgG antibodies improvement increased mortality Infection prevention local outbreaks Mann-Whitney U measure median MONITOR number of deaths Other over Patient patients PCR-positive polymerase chain polymerase chain reaction positive Prevent Prevention and control previous diagnosis proportion provide Real-Time Reverse Transcription Polymerase Chain Reaction receiving recruited renal renal disease Result reverse transcription reverse transcription polymerase chain reaction routine clinical practice rRT-PCR SARS-CoV-2 Serological testing Seroprevalence SKS SPSS statistical analysis supplementary material symptomatic Symptoms tested the antibody response the patient the vaccine the vaccines United Kingdom utility was performed were recorded were used with COVID-19
[DOI] 10.1186/s12882-021-02366-2 PMC 바로가기 [Article Type] Research

Systemic and organ-specific immune-related manifestations of COVID-19

Reviews

Published on 2021-04-262022-10-05
Journal: Nature reviews. Rheumatology [Category] SARS, 바이오마커, 치료기술,

SARS-CoV-2 Antibody Seroprevalence in Wuhan, China, from 23 April to 24 May 2020

2020년 4월 23일부터 5월 24일까지 중국 우한에서 SARS-CoV-2 항체 혈청 유행성

Research Article

Published on 2021-04-212022-09-10
Journal: mSphere [Category] MERS, SARS, 진단, 치료기술,

[키워드] age antibody asymptomatic patient asymptomatic patients Community conducted confirmed case confirmed cases contributed coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 antibody COVID-19 outbreak cumulative cumulative incidence estimate Face mask female IgG IgM incidence individual Infection Intervention outbreak positive COVID-19 prevalence of COVID-19 progression Public health intervention Public health interventions reported SARS-CoV-2 serologic test serologic tests Seroprevalence shown social distancing symptomatic patient Symptomatic patients tested Viral Viral RNA Wuhan Wuhan, China
[DOI] 10.1128/mSphere.01062-20 PMC 바로가기 [Article Type] Research Article